These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31809362)

  • 1. Forecasting Prevalence of HIV-1 Integrase Strand Transfer Inhibitor (INSTI) Drug Resistance: A Modeling Study.
    Northrop AJ; Pomeroy LW
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):65-71. PubMed ID: 31809362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary resistance to integrase strand-transfer inhibitors in Europe.
    Casadellà M; van Ham PM; Noguera-Julian M; van Kessel A; Pou C; Hofstra LM; Santos JR; Garcia F; Struck D; Alexiev I; Bakken Kran AM; Hoepelman AI; Kostrikis LG; Somogyi S; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Staneková D; Stanojevic M; Van Laethem K; Zidovec Lepej S; Clotet B; Boucher CA; Paredes R; Wensing AM;
    J Antimicrob Chemother; 2015 Oct; 70(10):2885-8. PubMed ID: 26188038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    Tzou PL; Rhee SY; Descamps D; Clutter DS; Hare B; Mor O; Grude M; Parkin N; Jordan MR; Bertagnolio S; Schapiro JM; Harrigan PR; Geretti AM; Marcelin AG; Shafer RW;
    J Antimicrob Chemother; 2020 Jan; 75(1):170-182. PubMed ID: 31617907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.
    Jeong W; Jung IY; Choi H; Kim JH; Seong H; Ahn JY; Jeong SJ; Ku NS; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):213-216. PubMed ID: 30229661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naïve individuals.
    Margot NA; Ram RR; White KL; Abram ME; Callebaut C
    J Med Virol; 2019 Dec; 91(12):2188-2194. PubMed ID: 31389026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
    Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
    Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice.
    Alvarez M; Casas P; de Salazar A; Chueca N; Guerrero-Beltran C; Rodríguez C; Imaz A; Espinosa N; García-Bujalance S; Pérez-Elías MJ; García-Alvarez M; Iribarren JA; Santos J; Dalmau D; Aguilera A; Vinuesa D; Gutiérrez F; Piérola B; Molina JM; Peraire J; Portilla I; Gómez-Sirvent JL; Olalla J; Galera C; Blanco JR; Riera M; García-Fraile L; Navarro G; Curran A; Poveda E; García F;
    J Antimicrob Chemother; 2019 Jun; 74(6):1693-1700. PubMed ID: 30838386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
    Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients.
    Sayan M; Gündüz A; Ersöz G; İnan A; Deveci A; Özgür G; Sargın F; Karagöz G; İnci A; İnan D; Ülçay A; Karaoğlan I; Kaya S; Kutlu SS; Süer K; Çağatay A; Akalın H
    HIV Clin Trials; 2016 May; 17(3):109-13. PubMed ID: 27125365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Communication: Trends in Transmitted Drug Resistance in Treatment-Naive HIV Patients in Korea.
    Jung EJ; Lee SH; Lee S; Lee JE; Lee SO; Park S; Kim HH; Kang JS; Woo HJ
    AIDS Res Hum Retroviruses; 2020 Nov; 36(11):905-909. PubMed ID: 32791842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
    Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
    Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
    Le Hingrat Q; Collin G; Lê M; Peytavin G; Visseaux B; Bertine M; Tubiana R; Karmochkine M; Valin N; Collin F; Lemaignen A; Bernard L; Damond F; Matheron S; Descamps D; Charpentier C;
    Clin Infect Dis; 2019 Aug; 69(4):657-667. PubMed ID: 30383215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants.
    Smith SJ; Zhao XZ; Burke TR; Hughes SH
    Retrovirology; 2018 May; 15(1):37. PubMed ID: 29769116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Integrase Strand Inhibitor Resistance (INSTI)in New Orleans, Louisiana, 2012-2013.
    Jeanfreau K; Sharma S; Frontini M; Khirfan M; Clark RA
    J La State Med Soc; 2015; 167(1):19-20. PubMed ID: 25978751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan.
    Chang SY; Lin PH; Cheng CL; Chen MY; Sun HY; Hsieh SM; Sheng WH; Su YC; Su LH; Chang SF; Liu WC; Hung CC; Chang SC
    Sci Rep; 2016 Oct; 6():35779. PubMed ID: 27779200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    Ambrosioni J; Nicolás D; Manzardo C; Agüero F; Blanco JL; Mosquera MM; Peñafiel J; Gatell JM; Marcos MA; Miró JM
    J Antimicrob Chemother; 2017 Jan; 72(1):205-209. PubMed ID: 27624569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
    Nguyen T; Fofana DB; Lê MP; Charpentier C; Peytavin G; Wirden M; Lambert-Niclot S; Desire N; Grude M; Morand-Joubert L; Flandre P; Katlama C; Descamps D; Calvez V; Todesco E; Marcelin AG
    J Antimicrob Chemother; 2018 Sep; 73(9):2485-2492. PubMed ID: 29873733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
    Henerico S; Lyimo E; Makubi AN; Magesa D; Desderius B; Mueller A; Changalucha J; Kalluvya SE; Van Zyl G; Preiser W; Mshana SE; Kasang C
    J Antimicrob Chemother; 2022 Oct; 77(11):3138-3143. PubMed ID: 36101479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors.
    Yoshinaga T; Seki T; Miki S; Miyamoto T; Suyama-Kagitani A; Kawauchi-Miki S; Kobayashi M; Sato A; Stewart E; Underwood M; Fujiwara T
    Antiviral Res; 2018 Apr; 152():1-9. PubMed ID: 29410019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
    Casadellà M; Santos JR; Noguera-Julian M; Micán-Rivera R; Domingo P; Antela A; Portilla J; Sanz J; Montero-Alonso M; Navarro J; Masiá M; Valcarce-Pardeiro N; Ocampo A; Pérez-Martínez L; Pasquau J; Vivancos MJ; Imaz A; Carmona-Oyaga P; Muñoz-Medina L; Villar-García J; Barrufet P; Paredes R;
    J Antimicrob Chemother; 2020 Dec; 75(12):3517-3524. PubMed ID: 32929472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.